BBH vs. XBI
Compare and contrast key facts about VanEck Vectors Biotech ETF (BBH) and SPDR S&P Biotech ETF (XBI).
BBH and XBI are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BBH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Biotech 25 Index. It was launched on Dec 20, 2011. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006. Both BBH and XBI are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBH or XBI.
Performance
BBH vs. XBI - Performance Comparison
Returns By Period
In the year-to-date period, BBH achieves a -1.79% return, which is significantly lower than XBI's 5.76% return. Over the past 10 years, BBH has underperformed XBI with an annualized return of 3.75%, while XBI has yielded a comparatively higher 4.95% annualized return.
BBH
-1.79%
-7.32%
-3.36%
8.12%
3.75%
3.75%
XBI
5.76%
-4.04%
5.72%
29.73%
1.44%
4.95%
Key characteristics
| BBH | XBI | |
|---|---|---|
| Sharpe Ratio | 0.52 | 1.18 |
| Sortino Ratio | 0.82 | 1.73 |
| Omega Ratio | 1.10 | 1.21 |
| Calmar Ratio | 0.27 | 0.54 |
| Martin Ratio | 2.10 | 3.96 |
| Ulcer Index | 4.15% | 7.86% |
| Daily Std Dev | 16.88% | 26.34% |
| Max Drawdown | -72.69% | -63.89% |
| Current Drawdown | -25.64% | -45.70% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BBH vs. XBI - Expense Ratio Comparison
Both BBH and XBI have an expense ratio of 0.35%.
Correlation
The correlation between BBH and XBI is 0.81, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Risk-Adjusted Performance
BBH vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BBH vs. XBI - Dividend Comparison
BBH's dividend yield for the trailing twelve months is around 0.44%, more than XBI's 0.15% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.44% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% | 0.17% |
Drawdowns
BBH vs. XBI - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.69%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for BBH and XBI. For additional features, visit the drawdowns tool.
Volatility
BBH vs. XBI - Volatility Comparison
The current volatility for VanEck Vectors Biotech ETF (BBH) is 6.84%, while SPDR S&P Biotech ETF (XBI) has a volatility of 8.40%. This indicates that BBH experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.